First of all, we started the quarter defining new R&D business lines for GalChimia. We are evaluating 4 innovative ideas, after an internal review on technical and sales aspects we will decide which new specialisation we are going to implement. You will know more about it once our decision will be taken, for the moment we are still on an exploratory phase!
We took part in 1 international event focused on Medicinal Chemistry – 52nd International Conference on Medicinal Chemistry: Interfacing Chemical Biology and Drug Discovery. This conference was held in the beautiful city of Caen in Normandy (France). We also started our business trips in Germany, so we went across the region of Baden-Württemberg and Brandenburg visiting different type of companies: Pharma, Biotech, or Biophysical.
This is year we will have to update our CIR accreditation and we decided to introduce Neogalfarma project to French authorities in order to present them a sample of our R&D activities.
That’s all for this quarter. More info in October for Q3.
